Montelukast sodium

Drug ingredient

CAS 151767-02-1

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 151767-02-1
1 Na⁺
US productionNot reported
Import value, 2024$111M
Top sourceIndia 28%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293349 · basket

These shares come from HS customs code 293349, which covers 94 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
IN 28%IndiaCN 27%ChinaSE 12%SwedenKR 10%South KoreaGB 4%United Kingdom
48 FDA-registered drug labelers
A-S Medication Solutions
Accord Healthcare Inc.
Ajanta Pharma USA Inc.
American Health Packaging
Amneal Pharmaceuticals LLC
Aphena Pharma Solutions - Tennessee, LLC
Aurobindo Pharma Limited
AvKARE
AvPAK
BluePoint Laboratories
Bryant Ranch Prepack
Camber Pharmaceuticals, Inc.
Cardinal Health 107, LLC
Chartwell RX, LLC
Direct_Rx
Dr. Reddy's Laboratories Limited
Hetero Drugs Limited
Lannett Company, Inc.
Laurus Labs Limited
Macleods Pharmaceutical Limited
Macleods Pharmaceuticals Limited
Major Pharmaceuticals
Matrix Pharmacorp Private Limited
Morepen Laboratories Limited
MSD International GmbH
MSN Pharmachem Private Limited
NuCare Pharmaceuticals, Inc.
Organon LLC
ORGANON PHARMA (UK) LIMITED
Patheon Manufacturing Services LLC
PD-Rx Pharmaceuticals, Inc.
PEL HEALTHCARE LLC
Preferred Pharmaceuticals Inc.
Professional Compounding Centers of America
Professional Compounding Centers of America dba PCCA
Proficient Rx LP
Quallent Pharmaceuticals Health LLC
Redpharm Drug
REMEDYREPACK INC.
Rising Pharma Holdings, Inc.
Sandoz Inc
Teva API India Private Ltd
Torrent Pharmaceuticals Limited
Unichem Laboratories Limited, India
Unichem Pharmaceuticals (USA), Inc.
Westminster Pharmaceuticals, LLC
XLCare Pharmaceuticals Inc.
Zenfold Sustainable Technologies Private Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • •montelukast sodium
  • •Montelukast
  • •Singulair
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Montelukast Sodium Tablet, Chewable

    Shortage listed since November 17, 2025

See all current drug shortages

Vendor Pricing

$4.80/gCombi-Blocks, Inc.
CountryUnited States
Pack$480.00 / 100 g
Purity97%
Vendors26 available

Prices reflect listed pack sizes. Small research packs run far above bulk rates.

Chemical Identity

CAS151767-02-1
PubChem CID23663996
DTXSIDDTXSID8046450
FormulaC35H35ClNNaO3S
Mol. Weight608.2 g/mol
SMILESCC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+]

Data Sources

Brief citations

Montelukast sodium (CAS 151767-02-1) https://chemicalindependence.com/chemical/151767-02-1/ PubChem: 23663996. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/23663996 FDA National Drug Code directory: CAS 151767-02-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 151767-02-1. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293349 for CAS 151767-02-1. Reporting year: 2024. https://usatrade.census.gov/